Merck Highlights New Data from Leading Lung Cancer Clinical Development Program at the IASLC 2019 World Conference on Lung Cancer

Pooled Overall Survival Data from Three Trials with KEYTRUDA® Plus Chemotherapy in Subgroup of Patients with Non-Small Cell Lung Cancer Whose Tumors Do

source https://finance.yahoo.com/news/merck-highlights-data-leading-lung-104500886.html?.tsrc=rss

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.